Beyond Cost-Benefit Analysis in the Governance of Synthetic Biology
For many innovations, oversight fits nicely within existing governance mechanisms; nevertheless, others pose unique public health, environmental, and ethical challenges. Synthetic artemisinin, for example, has many precursors in laboratory-developed drugs that emulate natural forms of the same drug....
| Authors: | ; ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2018
|
| In: |
The Hastings Center report
Year: 2018, Volume: 48, Pages: 70-77 |
| Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |
